The management of these patients required prolonged anti-tubercular therapy over a period of nine months based on 2 months of Ethambutol (20 mg/kg/24 h), Rifampicin (10 mg/kg/24 h), Isoniazid (5 mg/kg/24 h) and Pyrazinamide (25 mg/kg/24 h), then 7 months of Rifampicin (10 mg/kg/24 h) and Isoniazid (5 mg/kg/24 h).